MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Progressive supranuclear palsy(PSP)"

  • 2017 International Congress

    Clinicopathological analysis of corticobasal syndrome: a retrospective study

    R. Lamb, J. Rohrer, R. Weil, H. Ling, A. Lees, H. Morris (London, United Kingdom)

    Objective: Predicting underlying pathology in CBS. Background: Corticobasal syndrome (CBS) is pathologically heterogeneous.  CBS is one of the clinical phenotypes of corticobasal degeneration (CBD) but may…
  • 2017 International Congress

    Freezing of gait is an early clinical feature of progressive supranuclear palsy

    Y. Osaki, Y. Morita, Y. Miyamoto, T. Furushima, K. Furuta, H. Furuya (Nankoku, Japan)

    Objective: We attempted to identify any sign or symptom to diagnose progressive supranuclear palsy (PSP) earlier. Background: Early clinical diagnosis of progressive supranuclear palsy PSP…
  • 2017 International Congress

    Cognitive profiling in patients with Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy: a 15-month longitudinal study

    E. Fiorenzato, L. Weis, A. Antonini, R. Biundo (Venice-Lido, Italy)

    Objective: To characterize the progression of cognitive decline and compare the neuropsychological 15-month profile across PSP, MSA and PD. Background: Cognitive impairments are frequently reported in…
  • 2017 International Congress

    Do median-nerve evoked blink reflexes allow early differentiation between PD and PSP in patients with debuting parkinsonism?

    E. Nordh, J. Linder, L. Forsgren (UMEA, Sweden)

    Objective: Do median-nerve elicited blink reflex responses enable early differentiation between PD and PSP in patients with idiopathic parkinsonism?  Background: Differentiation between PD and PSP in…
  • 2017 International Congress

    Lifetime exposure to estrogen and risk for progressive supranuclear palsy

    H.K. Park, I. Litvan, S. Ilango (Goyang-si, Republic of Korea)

    Objective: To investigate the protective effect of estrogen on progressive supranuclear palsy (PSP).   Background: Animal and human epidemiologic studies of Parkinson’s disease and Alzheimer’s dementia have…
  • 2017 International Congress

    Perceptual and acoustical analysis of speech in multiple system atrophy and progressive supranuclear palsy.

    S. Contardi, A. Gessani, F. Cavallieri, C. Budriesi, A. Bernardi, M. Tondelli, E. Menozzi, A. Chiari, P. Nichelli, F. Valzania (Modena, Italy)

    Objective: The aim of this study was to characterize speech impairment in multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) with a standardized approach,…
  • 2017 International Congress

    Progressive Supranuclear Palsy : About one case at the Neurology Department – Dakar

    L. Belarabi, K. Toure, M. Ndiaye (Dakar, Senegal)

    Objective: We report an observation of a case received at the consultation in the Neurology Department of National Teaching Hospital Fann. Background: Progressive supranuclear palsy…
  • 2017 International Congress

    Tongue Strength in PSP

    H. Clark, J. Whitwell, J. Ahlskog, K. Josephs (Rochester, MN, USA)

    Objective: To describe anterior and posterior tongue elevation strength in participants with PSP Background: It is widely recognized that the tongue plays a critical role…
  • 2017 International Congress

    An evaluation of the diagnostic utility of radiological biomarkers in PSP

    J. Whitwell, G. Hoglinger, A. Antonini, Y. Bordelon, A. Boxer, C. Colosimo, R. Dodel, T. van Eimeren, L. Golbe, J. Kassubek, C. Kurz, I. Litvan, A. Pantelyat, G. Respondek, G. Rabinovici, J. Rowe, M. Stamelou, K. Josephs (Rochester, MN, USA)

    Objective: To critically evaluate the degree to which structural and molecular radiologic metrics fulfill criteria for diagnostic biomarkers of progressive supranuclear palsy (PSP). Background: PSP…
  • 2017 International Congress

    A PSP-like phenotype accompanies rapidly progressive dementia

    M. Dale, D. Erten-Lyons, F. Bittner, H.-Y. Jong, D. Bourdette, R. Woltjer (Charleston, SC, USA)

    Objective: We describe a patient with a progressive supranuclear palsy (PSP)-like phenotype and a rapidly progressive dementia, who was found to have an unknown CSF…
  • « Previous Page
  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
  • …
  • 42
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley